Resonance Specialties Limited (BOM:524218)

India flag India · Delayed Price · Currency is INR
99.00
-2.39 (-2.36%)
At close: Apr 17, 2026
Market Cap1.15B +28.3%
Revenue (ttm)899.72M +28.6%
Net Income88.58M +112.0%
EPS7.71 +113.0%
Shares Out11.54M
PE Ratio12.96
Forward PEn/a
Dividend1.00 (1.01%)
Ex-Dividend Daten/a
Volume1,258
Average Volume7,726
Open100.00
Previous Close101.39
Day's Range98.01 - 100.05
52-Week Range69.01 - 124.50
Beta0.03
RSI60.00
Earnings DateMay 19, 2026

About Resonance Specialties

Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in manufacturing agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; cyanopyridines that are applied in manufacturing of niacinamide; and picolines, including alpha, beta, and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate,... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1989
Employees 66
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524218
Full Company Profile

Financial Performance

In fiscal year 2025, Resonance Specialties's revenue was 778.07 million, an increase of 40.70% compared to the previous year's 553.01 million. Earnings were 65.66 million, an increase of 121.20%.

Financial Statements